CollPlant Biotechnologies (CLGN) Receivables - Net (2017 - 2025)
CollPlant Biotechnologies' (CLGN) quarterly Receivables - Net came in at $1000.0 in Q4 2025, down 100.0% YoY from $150.0 million in Q4 2024, and down 100.0% on a QoQ basis from $150.0 million in Q4 2024.
CollPlant Biotechnologies (CLGN) Receivables - Net (2017 - 2025) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 9 years of Receivables - Net data on file, last reported at $1000.0 in Q4 2025.
- Quarterly Receivables - Net fell 100.0% year-over-year to $1000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1000.0 (down 100.0% YoY) and the FY2025 annual result came in at $1000.0, down 100.0% from the prior year.
- Receivables - Net slipped to $1000.0 in Q4 2025, from $150.0 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $270.0 billion in Q4 2021 to a low of $1000.0 in Q4 2025.
- A 5-year average of $18.0 billion and a median of $4.0 million in 2023 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2021 — Receivables - Net surged 32530020.48% — and 2025, when it sank 100.0%.
- Tracing CLGN's Receivables - Net over 5 years: stood at $270.0 billion in 2021, then slumped by 100.0% to $9.0 million in 2022, then slumped by 55.56% to $4.0 million in 2023, then soared by 3650.0% to $150.0 million in 2024, then slumped by 100.0% to $1000.0 in 2025.
- The last three Receivables - Net figures came in at $1000.0 (Q4 2025), $150.0 million (Q4 2024), and $5.0 million (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.23 Bn | 132.38 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.97 Bn | 78.97 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 59.88 Bn | 54.74 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.20 Bn | 37.11 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.69 Bn | 10.30 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - |
| 10 | CollPlant Biotechnologies | 4.40 Mn | 4.40 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 150.00 Mn |
| Dec 31, 2024 | 150.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 250,000.00 |
| Jun 30, 2024 | 250,000.00 |
| Mar 31, 2024 | 90.00 Mn |
| Mar 31, 2024 | 90.00 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 10.16 Mn |
| Jun 30, 2023 | 10.16 Mn |
| Mar 31, 2023 | 323,000.00 |
| Mar 31, 2023 | 323,000.00 |
| Dec 31, 2022 | 9.00 Mn |
| Dec 31, 2022 | 9.00 Mn |
| Sep 30, 2022 | 9,000.00 |
| Sep 30, 2022 | 9,000.00 |